scholarly article | Q13442814 |
P50 | author | Silvi Shah | Q88496225 |
P2093 | author name string | Prasoon Verma | |
P2860 | cites work | Antiplatelet agents for preventing pre-eclampsia and its complications | Q24245285 |
Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients | Q33457785 | ||
Pregnancy and maternal outcomes among kidney transplant recipients | Q33561703 | ||
Presynaptic modulation of cortical synaptic activity by calcineurin. | Q34111952 | ||
Cyclosporine and its metabolites in mother and baby | Q34241654 | ||
Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus | Q34698643 | ||
Pregnancy in renal transplantation: immunologic evaluation of neonates from mothers with transplanted kidney | Q34786091 | ||
Immunosuppression in pregnancy: choices for infant and maternal health | Q34978718 | ||
Pregnancy after kidney transplantation | Q35153313 | ||
Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities | Q35634923 | ||
Outcomes associated with hypogonadism in women with chronic kidney disease. | Q35922243 | ||
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation | Q36155827 | ||
Pregnancy in renal transplant recipients: a UK national cohort study | Q36583355 | ||
Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants | Q36733578 | ||
Obstetric considerations in the management of pregnancy in kidney transplant recipients | Q36774666 | ||
Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis | Q37906788 | ||
Immunosuppressive drugs and fetal outcome | Q38245058 | ||
Breast-feeding after transplantation | Q38255761 | ||
U.S. Selected Practice Recommendations for Contraceptive Use, 2016. | Q38911089 | ||
Timing of Pregnancy After Kidney Transplantation and Risk of Allograft Failure | Q39945636 | ||
Renal hemodynamics and tubular function normal human pregnancy | Q40295235 | ||
Aicardi's Syndrome: Are Corticosteroids Teratogens? | Q42590038 | ||
Intrauterine contraceptive device failures in renal transplant patients | Q43656281 | ||
The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons | Q43823404 | ||
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients | Q44046247 | ||
Pregnancy outcome after renal transplantation | Q44431241 | ||
Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis--a multicentre study. | Q44918170 | ||
Azathioprine treatment during lactation | Q46398743 | ||
Postmarketing surveillance for human teratogenicity: a model approach. | Q46607993 | ||
Successful pregnancies in women on renal replacement therapy: Report from the EDTA Registry | Q47669766 | ||
Pregnancy after organ transplantation: a report from the UK Transplant pregnancy registry | Q47853836 | ||
The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation. | Q51065307 | ||
Contraceptive counseling and use among 197 female kidney transplant recipients. | Q51683712 | ||
The experience of pregnancy after renal transplantation: pregnancies even within postoperative 1 year may be tolerable. | Q51701348 | ||
Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. | Q51771916 | ||
Developmental well-being in offspring of women receiving cyclosporine post-renal transplant. | Q52178600 | ||
Teratology: general considerations and principles. | Q52179738 | ||
Uric acid handling, pregnancy and cyclosporin in renal transplant women | Q68593753 | ||
Cyclosporine A prevents the generation of single positive (Lyt2+ L3T4-, Lyt2- L3T4+) mature T cells, but not single positive (Lyt2+ T3-) Immature thymocytes, in newborn mice | Q69411711 | ||
The effect of pregnancy on kidney function in renal allograft recipients | Q69886891 | ||
The transplacental passage of prednisone and prednisolone in pregnancy near term | Q70514921 | ||
Pharmacokinetics of prednisolone transfer to breast milk | Q70612070 | ||
Gynecologic and reproductive issues in women on dialysis | Q73355682 | ||
Pregnancy post-transplant: the establishment of a UK registry | Q73794324 | ||
Breast-feeding during treatment with cyclosporine | Q74150571 | ||
Pregnancy outcomes in female renal transplant recipients | Q77175950 | ||
Pregnancy during dialysis: case report and management guidelines | Q77741185 | ||
Time course of serum prolactin and sex hormones following successful renal transplantation | Q78354542 | ||
Menstrual disturbances and alternations in hypophyseal gonadal axis in end-stage premenopausal women undergoing hemodialysis: a multi-center study | Q79183142 | ||
Successful pregnancies after human renal transplantation | Q79450128 | ||
Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation | Q84426738 | ||
Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products | Q86976264 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 4539342 | |
P577 | publication date | 2016-11-30 | |
P1433 | published in | International Journal of Nephrology | Q26842036 |
P1476 | title | Overview of Pregnancy in Renal Transplant Patients | |
P478 | volume | 2016 |
Q90705186 | Azathioprine-induced Agranulocytosis and Severe Alopecia After Kidney Transplantation Associated With a NUDT15 Polymorphism: A Case Report |
Q64055596 | Effect of deflazacort on pregnancy outcome in kidney transplant patients: should we change the immunosuppressant before conception? |
Q60953500 | Fetal Toxicity of Immunosuppressive Drugs in Pregnancy |
Q87866782 | Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era |
Q89942220 | Instructions for kidney recipients and donors (In English for medical providers and in Arabic for patients and donors) |
Q40115721 | Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis. |
Q89047737 | Preeclampsia Risks in Kidney Donors and Recipients |
Q87623122 | Pregnancy After Renal Transplantation |
Q92418111 | Pregnancy Outcomes After Liver Transplantation: A Systematic Review |
Q61444939 | Pregnancy outcomes in women with kidney transplant: Metaanalysis and systematic review |
Q90286779 | Racial Differences and Factors Associated with Pregnancy in ESKD Patients on Dialysis in the United States |
Q92524725 | Racial disparities and factors associated with pregnancy in kidney transplant recipients in the United States |
Q41116538 | Recent advances in the molecular mechanisms of Mayer-Rokitansky-Küster-Hauser syndrome |
Q92567258 | Successful pregnancy after in vitro fertilization in an ABO-incompatible kidney transplant recipient receiving rituximab: a case report |
Q89519421 | Successful retrieval of oocytes from renal transplant recipient followed by surrogacy |
Q92551837 | Use of Tacrolimus During Pregnancy After Kidney Transplantaion |
Search more.